Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $3.9 million.

  • Burning Rock Biotech's Total Non-Current Liabilities fell 6534.39% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 6534.39%. This contributed to the annual value of $5.2 million for FY2024, which is 35164.08% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Total Non-Current Liabilities of $3.9 million as of Q3 2025, which was down 6534.39% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Total Non-Current Liabilities registered a high of $38.2 million during Q4 2021, and its lowest value of $1.2 million during Q4 2023.
  • In the last 5 years, Burning Rock Biotech's Total Non-Current Liabilities had a median value of $5.2 million in 2024 and averaged $7.8 million.
  • As far as peak fluctuations go, Burning Rock Biotech's Total Non-Current Liabilities soared by 5087600.0% in 2021, and later crashed by 9329.62% in 2022.
  • Burning Rock Biotech's Total Non-Current Liabilities (Quarter) stood at $38.2 million in 2021, then tumbled by 93.3% to $2.6 million in 2022, then plummeted by 54.82% to $1.2 million in 2023, then soared by 351.64% to $5.2 million in 2024, then fell by 26.2% to $3.9 million in 2025.
  • Its Total Non-Current Liabilities was $3.9 million in Q3 2025, compared to $4.3 million in Q2 2025 and $4.2 million in Q1 2025.